Correlation Between HTG Molecular and Castle Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HTG Molecular and Castle Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HTG Molecular and Castle Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HTG Molecular Diagnostics and Castle Biosciences, you can compare the effects of market volatilities on HTG Molecular and Castle Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HTG Molecular with a short position of Castle Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of HTG Molecular and Castle Biosciences.

Diversification Opportunities for HTG Molecular and Castle Biosciences

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between HTG and Castle is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding HTG Molecular Diagnostics and Castle Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Castle Biosciences and HTG Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HTG Molecular Diagnostics are associated (or correlated) with Castle Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Castle Biosciences has no effect on the direction of HTG Molecular i.e., HTG Molecular and Castle Biosciences go up and down completely randomly.

Pair Corralation between HTG Molecular and Castle Biosciences

Given the investment horizon of 90 days HTG Molecular Diagnostics is expected to under-perform the Castle Biosciences. In addition to that, HTG Molecular is 3.47 times more volatile than Castle Biosciences. It trades about 0.0 of its total potential returns per unit of risk. Castle Biosciences is currently generating about 0.06 per unit of volatility. If you would invest  1,433  in Castle Biosciences on August 31, 2024 and sell it today you would earn a total of  1,595  from holding Castle Biosciences or generate 111.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy8.56%
ValuesDaily Returns

HTG Molecular Diagnostics  vs.  Castle Biosciences

 Performance 
       Timeline  
HTG Molecular Diagnostics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Castle Biosciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Castle Biosciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Castle Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

HTG Molecular and Castle Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HTG Molecular and Castle Biosciences

The main advantage of trading using opposite HTG Molecular and Castle Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HTG Molecular position performs unexpectedly, Castle Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Castle Biosciences will offset losses from the drop in Castle Biosciences' long position.
The idea behind HTG Molecular Diagnostics and Castle Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges